2000
DOI: 10.1002/1097-0029(20000915)50:6<532::aid-jemt10>3.0.co;2-e
|View full text |Cite
|
Sign up to set email alerts
|

Smooth muscle myosin heavy chain isoforms and their role in muscle physiology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
54
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 77 publications
(56 citation statements)
references
References 69 publications
1
54
0
Order By: Relevance
“…34 -36 To further define the SMC population and to identify the presence of myofibroblasts, antibodies against ␣-SMA and smooth-muscle myosin heavy chain (SM2 or Myh11) were also used. 37,38 Results from the present study demonstrated an increase in the number of DDR2 ϩ cells at 8-and 16-weeks post-TAA induction, suggesting an increase in the number of fibroblasts or fibroblast-derived cells at these time points. Interestingly, this occurred concomitantly with an increase in smooth-muscle myosin staining (Myh11).…”
Section: Analysis Of Taa-induced Cellular Constituentsmentioning
confidence: 48%
“…34 -36 To further define the SMC population and to identify the presence of myofibroblasts, antibodies against ␣-SMA and smooth-muscle myosin heavy chain (SM2 or Myh11) were also used. 37,38 Results from the present study demonstrated an increase in the number of DDR2 ϩ cells at 8-and 16-weeks post-TAA induction, suggesting an increase in the number of fibroblasts or fibroblast-derived cells at these time points. Interestingly, this occurred concomitantly with an increase in smooth-muscle myosin staining (Myh11).…”
Section: Analysis Of Taa-induced Cellular Constituentsmentioning
confidence: 48%
“…Among highly downregulated transcripts, there were inhibitors of DNA binding 1 (ID1), cell division cycle 20 (CDC20) and ubiquitin-conjugating enzyme E2C (UBE2C). MYH11 and its isoforms are differentially expressed during muscle cell maturation [45]. It has frequently been reported that CSCs are committed to all cardiac lineages (cardiomyocytes, endothelial, and smooth muscle cells) [29,32,46,47].…”
Section: Discussionmentioning
confidence: 99%
“…The reverse regulation pattern of down regulated non-adipogenic gene products (e.g. jagged 1, JAG1 correlated with osteogenesis (Nobta et al, 2005) and angiogenesis (Uyttendaele et al, 2000), CYR61 involved in angiogenesis (Lau and Lam, 1999;Schutze et al, 2005a), muscle-associated tropomyosin 1 (alpha), cysteine and glycine-rich protein 2, CSRP2, myosin heavy polypeptide 11 smooth muscle, and villin 2 A c c e p t e d M a n u s c r i p t -17 -(ezrin), VIL2 (MacLeod and Gooding, 1988;Louis et al, 1997;Babu et al, 2000;Moyen et al, 2004)) and up regulated adipogenesis-related gene products (C/EBPα, LPL and acetyl-CoA carboxylase β (Rosen et al, 2002;Wu et al, 1999;Fried et al, 1993;Spiegelman et al, 1993), and two glucose transporter molecules SLC2A3 and SLC2A14) could contribute to the switch of preosteoblasts into adipocytes during transdifferentiation. Furthermore, the initiation of transdifferentiation could involve other factors and signaling pathways that have not been described in the context of direct differentiation or whose functions have not been revealed so far.…”
Section: Accepted Manuscript -16 -mentioning
confidence: 99%